About the PMPRB

The PMPRB protects and informs Canadians by ensuring that the prices of patented medicines sold in Canada are not excessive and by reporting on pharmaceutical trends.

photo
Did you know?

Changes in prescription drug expenditures are driven by a number of opposing “push” and “pull” effects, such as generic substitution and increased use of higher-cost drugs.

The newly launched NPDUIS CompassRx report will provide you with insight into the high-impact cost drivers in Canadian Public Drug plans.

photo
Did you know?

The PMPRB supports health care decision making in Canada through the NPDUIS research initiative.

Find out more…

photo
Did you know?

Patentees are required by law to file information pertaining to the sale of their drug products in Canada to ensure that the prices are not excessive. Approximately 1,300 drug products are currently under the jurisdiction of the PMPRB.

Find out more…

photo
Did you know?

The PMPRB reports on the sales and price trends of patented drug products as well as pharmaceutical research and development spending in Canada.

Find out more…

photo
Did you know?

A recently released NPDUIS report has identified 27 drugs under development, including nine new biologics, that may have an impact on future drug plan expenditures in Canada.

Read the full report: New Drug Pipeline Monitor,
sixth edition

I am a/an...

Consumer

Patentee

Other Stakeholder

Features